Establishment Labs Valuation Multiples

Establishment Labs Overview

About Establishment Labs

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Founded

2004

HQ

Employees

1.0K

Website

establishmentlabs.com

Sectors

Medical DevicesBioTechLongevity

Financials (LTM)

Revenue: $227M

EBITDA: ($6M)

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Establishment Labs Financials

Establishment Labs reported last 12-month revenue of $227M and negative EBITDA of ($6M).

In the same LTM period, Establishment Labs generated $159M in gross profit, ($6M) in EBITDA losses, and had net loss of ($45M).

Establishment Labs P&L

In the most recent fiscal year, Establishment Labs reported revenue of $211M and EBITDA of ($14M).

Establishment Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX

Establishment Labs Stock Performance

Establishment Labs has current market cap of $2B, and enterprise value of $2B.

Establishment Labs' stock price is $67.10.

Establishment Labs Valuation Multiples

Establishment Labs trades at 9.5x EV/Revenue multiple, and (390.1x) EV/EBITDA.

Establishment Labs Financial Valuation Multiples

As of April 20, 2026, Establishment Labs has market cap of $2B and EV of $2B.

Equity research analysts estimate Establishment Labs' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Establishment Labs has a P/E ratio of (44.0x).

Establishment Labs Margins & Growth Rates

Establishment Labs' revenue in the last 12 month grew by 26%.

Establishment Labs' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Establishment Labs' rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Establishment Labs' rule of X is 69% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Establishment Labs Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Establishment Labs M&A Activity

Establishment Labs acquired XXX companies to date.

Last acquisition by Establishment Labs was on XXXXXXXX, XXXXX. Establishment Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Establishment Labs Investment Activity

Establishment Labs invested in XXX companies to date.

Establishment Labs made its latest investment on XXXXXXXX, XXXXX. Establishment Labs invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).